HK Stock MarketDetailed Quotes

02367 GIANT BIOGENE

Watchlist
  • 49.400
  • -1.900-3.70%
Trading Dec 9 13:59 CST
50.79BMarket Cap26.22P/E (TTM)

GIANT BIOGENE Key Stats

GIANT BIOGENE Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 2.558B--
Aug 19, 20242024/H12.540B / 2.265B--
Mar 25, 20242023/H21.918B / 1.842B--
Aug 28, 20232023/H11.606B / 1.471B--
Mar 27, 20232022/H21.641B / 1.177B--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 2.558B--
Aug 19, 20242024/H12.540B / 2.265B--
Mar 25, 20242023/H21.918B / 1.842B--
Aug 28, 20232023/H11.606B / 1.471B--
Mar 27, 20232022/H21.641B / 1.177B--

Unlock Free Earnings Estimates

GIANT BIOGENE Earnings Reports

Read more

Trending HK Stocks
HK Crypto ETF HK Crypto ETF

An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 9, 2024

Strong Buy

  • Strong Buy

    87.81%
  • Buy

    12.20%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data